Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.59T | 1.60T | 1.62T | 1.75T | 1.61T | Gross Profit |
431.49B | 448.77B | 464.96B | 521.04B | 460.65B | EBIT |
41.49B | 44.07B | 65.70B | 92.08B | 38.33B | EBITDA |
67.10B | 69.19B | 90.13B | 113.93B | 59.10B | Net Income Common Stockholders |
24.05B | 31.82B | 50.55B | 51.80B | 24.61B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
55.24B | 47.24B | 57.18B | 74.44B | 48.94B | Total Assets |
1.29T | 1.27T | 1.27T | 1.25T | 1.16T | Total Debt |
315.83B | 319.54B | 238.14B | 235.25B | 247.12B | Net Debt |
260.60B | 272.30B | 180.95B | 160.82B | 198.18B | Total Liabilities |
664.82B | 659.41B | 595.39B | 580.06B | 518.33B | Stockholders Equity |
618.64B | 606.58B | 658.43B | 650.99B | 637.01B |
Cash Flow | Free Cash Flow | |||
28.22B | 22.20B | -8.47B | 98.99B | 42.62B | Operating Cash Flow |
54.56B | 43.74B | 21.08B | 122.28B | 62.43B | Investing Cash Flow |
-21.91B | -25.21B | -22.27B | -14.78B | -8.23B | Financing Cash Flow |
-25.59B | -29.45B | -16.65B | -82.84B | -58.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €263.11B | 15.16 | 11.19% | 2.76% | 11.59% | 305.12% | |
74 Outperform | ¥83.67B | 17.21 | 1.47% | 6.46% | 67.90% | ||
74 Outperform | ¥119.06B | 14.29 | 5.29% | 4.38% | 10.39% | ||
64 Neutral | $384.98B | 14.09 | 3.48% | 2.64% | 1.27% | -19.36% | |
61 Neutral | ¥212.66B | 27.39 | 3.22% | 0.93% | -39.44% | ||
61 Neutral | $6.58B | 11.81 | 3.06% | 3.99% | 2.54% | -21.54% |